A pioneering vaccine developed using the same mRNA technology as Covid jabs has raised hopes of a cure for pancreatic cancer.
Half of patients given the vaccine, designed to prevent cancer returning after surgery, remained free of the disease 18 months later.
The vaccine was developed by US scientists in collaboration with BioNTech, the German firm behind the Pfizer coronavirus jab.
The cancer vaccine uses the same mRNA technology used by BioNTech to create the Pfizer coronavirus jab
GETTY IMAGES
Pancreatic cancer is the deadliest common cancer, with 90 per cent of patients dying within two years of diagnosis.
It kills 10,000 a year in the UK — similar to the number who die from breast cancer — and there has been no improvement in survival rates or treatment breakthroughs for decades.
But a groundbreaking trial, presented at the American Society of Clinical